Drug Profile


Alternative Names: Celecoxib/amlodipine; KIT 302

Latest Information Update: 31 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Kitov Pharmaceuticals
  • Class Antihypertensives; Antirheumatics; Dihydropyridines; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Pyrazoles; Small molecules; Sulfonamides
  • Mechanism of Action Calcium channel antagonists; Cyclo-oxygenase 2 inhibitors; Cytochrome P 450 enzyme system inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preregistration Hypertension; Pain

Most Recent Events

  • 26 Oct 2017 Efficacy data from a phase III/IV trial in Hypertension released by Kitov Pharmaceuticals
  • 02 Oct 2017 The US Food and Drug Administration (FDA) accepts NDA for Amlodipine/celecoxib for Pain and Hypertension for review
  • 31 Jul 2017 Preregistration for Hypertension in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top